SPUR Trademark
Trademark Overview
On Tuesday, March 4, 2025, a trademark application was filed for SPUR with the United States Patent and Trademark Office. The USPTO has given the SPUR trademark a serial number of 79422215. The federal status of this trademark filing is REGISTERED as of Tuesday, May 12, 2026. This trademark is owned by Spur Therapeutics Limited. The SPUR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use.
Pharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned being related to human health.
General Information
| Serial Number | 79422215 |
| Word Mark | SPUR |
| Filing Date | Tuesday, March 4, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 12, 2026 |
| Registration Number | 8248569 |
| Registration Date | Tuesday, May 12, 2026 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 24, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use. |
| Goods and Services | Pharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned being related to human health. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 24, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 24, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Spur Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Spur Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Spur Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, April 24, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, April 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, August 6, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, August 7, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 16, 2025 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 17, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 3, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, February 12, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 12, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 12, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 2, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 18, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 24, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 24, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 12, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 12, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
